AlertWatch

AlertWatch is a health technology company specializing in advanced remote patient monitoring solutions, integrating vital sign data to improve patient care and clinical workflows in healthcare settings. AlertWatch is known for its innovative approach to patient monitoring. Founded in 2011 in Ann Arbor, US, the company has pivoted its strategy by being acquired by BioIntelliSense, Inc. in October 2022.

The acquisition allows for an expanded portfolio of continuous monitoring solutions. Kevin Tremper, the founder, is recognized for his contributions to the healthcare technology sector. AlertWatch offers advanced remote patient monitoring solutions, focusing on enhancing care with its flagship BioButton® multi-parameter wearable device and BioDashboard™ system. These products are designed for continuous vital sign monitoring, improving clinical workflows and enabling personalized patient care.

The company primarily targets hospitals and healthcare systems in the U. S. market, with plans for selective global market expansion. AlertWatch generates revenue through B2B transactions with healthcare institutions utilizing its remote monitoring solutions.

Its business model includes subscription-based services for the BioCloud™ data analytics platform, in addition to the sales of its medical-grade wearables, facilitating continuous monitoring critical for patient management. In the wake of the acquisition by BioIntelliSense, Inc. , AlertWatch aims to strengthen its offerings in continuous patient monitoring. The company plans to expand its market reach, leveraging the recent funding from the Series A round, amounting to USD 3.

36 mn, to enhance product development and support entry into new healthcare markets. This strategic move will facilitate the introduction of new products aimed at improving patient outcomes while optimizing healthcare operations.